Humana AB (publ) (STO:HUM)
Sweden · Delayed Price · Currency is SEK 70.80
-0.30 (-0.42%)
Oct 15, 2026, 2:53 PM CET
Humana AB Market Cap
Humana AB has a market cap or net worth of 3.36 billion as of October 14, 2026. It is the 17,487th most valuable company in the world and the 220th biggest in Sweden. Its market cap has increased by 59.77% in one year.
Market Cap
3.36B
Enterprise Value
7.51B
Revenue
10.04B
Global Rank
Country Rank
#220 Sweden
PE Ratio
19.70
ChartMarket Cap Chart
Since March 22, 2016, Humana AB's market cap has decreased from 3.40B to 3.36B, a decrease of -0.91%. That is a compound annual growth rate of -0.09%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 15, 2026 | 3.36B | 35.64% |
| Dec 30, 2025 | 2.48B | 34.25% |
| Dec 30, 2024 | 1.85B | 37.23% |
| Dec 29, 2023 | 1.35B | -26.88% |
| Dec 30, 2022 | 1.84B | -48.20% |
| Dec 30, 2021 | 3.55B | 18.94% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Swedish Orphan Biovitrum AB | 148.67B |
| Getinge AB | 69.26B |
| Sectra AB | 59.65B |
| Medicover AB | 39.97B |
| Egetis Therapeutics AB | 4.46B |
| CellaVision AB | 3.95B |
| Hansa Biopharma AB | 3.52B |
| Surgical Science Sweden AB | 2.76B |